Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8273551rdf:typepubmed:Citationlld:pubmed
pubmed-article:8273551lifeskim:mentionsumls-concept:C0085979lld:lifeskim
pubmed-article:8273551lifeskim:mentionsumls-concept:C0243192lld:lifeskim
pubmed-article:8273551lifeskim:mentionsumls-concept:C0079043lld:lifeskim
pubmed-article:8273551lifeskim:mentionsumls-concept:C0348016lld:lifeskim
pubmed-article:8273551lifeskim:mentionsumls-concept:C0205263lld:lifeskim
pubmed-article:8273551lifeskim:mentionsumls-concept:C0167318lld:lifeskim
pubmed-article:8273551pubmed:dateCreated1994-1-31lld:pubmed
pubmed-article:8273551pubmed:abstractTextThe direct effect of intratracheal (IT) administration of human major basic protein (MBP) on pulmonary inspiratory pressure (PIP), and the effect on agonist-induced change in PIP, were determined in anesthetized, ventilated guinea pigs. 500 micrograms MBP increased PIP from 24.1 +/- 4.3 to 49.8 +/- 7.4 cmH2O (p < 0.002, n = 10). Maximum PIP was achieved within 30 min after 500 micrograms MBP. The direct PIP response to 250 micrograms MBP was not different from vehicle. The PIP responses to intravenous (IV) acetylcholine (Ach) and 5-hydroxytryptamine (5-HT) were measured before and after administration of 250 micrograms MBP (n = 12). MBP caused a modest, but significant potentiation of the increase in PIP induced by 1, 3 and 10 micrograms/kg Ach (24, 32 and 28%, respectively, p < 0.02) and to 1 microgram/kg 5-HT (43% p < 0.02). We conclude that MBP at a dose that does not directly affect inspiratory pressure is capable of augmenting the PIP response to IV Ach and 5-HT in vivo.lld:pubmed
pubmed-article:8273551pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8273551pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8273551pubmed:languageenglld:pubmed
pubmed-article:8273551pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8273551pubmed:citationSubsetIMlld:pubmed
pubmed-article:8273551pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8273551pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8273551pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8273551pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8273551pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8273551pubmed:statusMEDLINElld:pubmed
pubmed-article:8273551pubmed:issn0065-4299lld:pubmed
pubmed-article:8273551pubmed:authorpubmed-author:PiperP JPJlld:pubmed
pubmed-article:8273551pubmed:authorpubmed-author:LettsL GLGlld:pubmed
pubmed-article:8273551pubmed:authorpubmed-author:GleichG JGJlld:pubmed
pubmed-article:8273551pubmed:authorpubmed-author:DesaiS NSNlld:pubmed
pubmed-article:8273551pubmed:authorpubmed-author:RobsonJJlld:pubmed
pubmed-article:8273551pubmed:authorpubmed-author:ValEElld:pubmed
pubmed-article:8273551pubmed:authorpubmed-author:NoonanT CTClld:pubmed
pubmed-article:8273551pubmed:authorpubmed-author:GundelR HRHlld:pubmed
pubmed-article:8273551pubmed:issnTypePrintlld:pubmed
pubmed-article:8273551pubmed:volume39 Spec Nolld:pubmed
pubmed-article:8273551pubmed:ownerNLMlld:pubmed
pubmed-article:8273551pubmed:authorsCompleteYlld:pubmed
pubmed-article:8273551pubmed:paginationC132-5lld:pubmed
pubmed-article:8273551pubmed:dateRevised2007-11-14lld:pubmed
pubmed-article:8273551pubmed:meshHeadingpubmed-meshheading:8273551-...lld:pubmed
pubmed-article:8273551pubmed:meshHeadingpubmed-meshheading:8273551-...lld:pubmed
pubmed-article:8273551pubmed:meshHeadingpubmed-meshheading:8273551-...lld:pubmed
pubmed-article:8273551pubmed:meshHeadingpubmed-meshheading:8273551-...lld:pubmed
pubmed-article:8273551pubmed:meshHeadingpubmed-meshheading:8273551-...lld:pubmed
pubmed-article:8273551pubmed:meshHeadingpubmed-meshheading:8273551-...lld:pubmed
pubmed-article:8273551pubmed:meshHeadingpubmed-meshheading:8273551-...lld:pubmed
pubmed-article:8273551pubmed:meshHeadingpubmed-meshheading:8273551-...lld:pubmed
pubmed-article:8273551pubmed:meshHeadingpubmed-meshheading:8273551-...lld:pubmed
pubmed-article:8273551pubmed:meshHeadingpubmed-meshheading:8273551-...lld:pubmed
pubmed-article:8273551pubmed:meshHeadingpubmed-meshheading:8273551-...lld:pubmed
pubmed-article:8273551pubmed:meshHeadingpubmed-meshheading:8273551-...lld:pubmed
pubmed-article:8273551pubmed:year1993lld:pubmed
pubmed-article:8273551pubmed:articleTitleHuman eosinophil major basic protein augments bronchoconstriction induced by intravenous agonists in guinea pigs.lld:pubmed
pubmed-article:8273551pubmed:affiliationBoehringer Ingelheim Pharmaceuticals Inc., Ridgefield, CT 06877-0368.lld:pubmed
pubmed-article:8273551pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:8273551pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed